Table 5

Sensitivity analysis: results of the multivariable logistic regression analyses of psychiatric sequelae after COVID-19 infection

	Acute: 1–3 months after COVID-19 infection				Delayed: 4–6 months after COVID-19 infection
	COVID-19 vs influenza		COVID-19 vs other RTI		COVID-19 vs influenza		COVID-19 vs other RTI
	OR (95% CI)	P value	OR (95% CI)	P value	OR (95% CI)	P value	OR (95% CI)	P value
Mood/anxiety/psychotic disorder	1.38 (1.02 to 1.87)	0.038	0.77 (0.60 to 0.99)	0.045	1.09 (0.70 to 1.70)	0.688	0.62 (0.42 to 0.91)	0.097
Mood disorder	1.55 (1.05 to 2.29)	0.026	0.97 (0.71 to 1.32)	0.823	0.76 (0.42 to 1.38)	0.372	0.50 (0.29 to 0.85)	0.190
Anxiety disorder	1.04 (0.62 to 1.74)	0.885	0.51 (0.35 to 0.76)	0.001	1.15 (0.54 to 2.43)	0.715	0.56 (0.30 to 1.03)	0.011
Psychotic disorder	1.79 (1.19 to 2.70)	0.005	0.77 (0.56 to 1.05)	0.097	1.27 (0.69 to 2.35)	0.436	0.56 (0.34 to 0.94)	0.027
Insomnia	2.88 (2.18 to 3.81)	<0.001	1.80 (1.42 to 2.27)	<0.001	1.22 (0.82 to 1.80)	0.322	0.69 (0.49 to 0.98)	0.036

In this sensitivity analysis, psychiatric sequelae were defined using both recorded diagnoses and drug prescriptions.
COVID-19, coronavirus disease 2019; RTI, respiratory tract infection.